alitretinoin topical (cont.)
IN THIS ARTICLE
Who should not use alitretinoin topical (Panretin)?
Before using alitretinoin topical, tell your doctor if you have cutaneous T-cell lymphoma. You may not be able to use alitretinoin topical, or you may require a dosage adjustment or special monitoring during your treatment.
Alitretinoin topical is the FDA pregnancy category D. This means that alitretinoin topical may be harmful to an unborn baby. Alitretinoin topical has caused birth defects in animal studies. Do not use alitretinoin topical without first talking to your doctor if you are pregnant or could become pregnant during treatment.
It is not known whether alitretinoin topical passes into breast milk. Do not use alitretinoin topical without first talking to your doctor if you are breast-feeding a baby.
How should I use alitretinoin topical (Panretin)?
Use alitretinoin topical exactly as directed by your doctor. If you do not understand these instructions, ask your pharmacist, nurse, or doctor to explain them to you.
Wash your hands before and after applying this medication.
Apply enough gel to cover the lesion with a generous coating. Allow the gel to dry for 3 to 5 minutes before covering the area with clothing.
Do not apply alitretinoin topical to normal skin surrounding a lesion. Also, do not apply alitretinoin topical on or near mucosal surfaces of the body such as the inside of the nose or mouth.
Do not cover the treated lesions with any type of occlusive dressing (a dressing that does not allow air to circulate to the area).
Alitretinoin topical is usually applied two to four times a day. Follow your doctor's instructions.
Store alitretinoin topical at room temperature away from moisture and heat.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Need help identifying pills and medications?
Get the latest treatment options.